Mayo Clinic Revealed as a Top Shareholder of Hyped Silicon Valley Anti-Aging Co.
Mayo Clinic Revealed as a Top Shareholder of Hyped Silicon Valley Anti-Aging Co.

San Francisco anti-aging firm seeks $85 million for clinical trials using Mayo intelligence.

Boston Scientific Buys Ovarian Cancer Diagnosis Device Maker in $275M Deal
Boston Scientific Buys Ovarian Cancer Diagnosis Device Maker in $275M Deal

The medical device giant expects the deal could one day be huge, entering it into a market valued between $500 million and $2 billion.

U of M, Biocept Collaboration Targeting Testicular Cancer Shows Promise
U of M, Biocept Collaboration Targeting Testicular Cancer Shows Promise

Use of ‘liquid biopsies’ to track disease progression found to be feasible.

Inspire Medical Systems Announces $86M IPO
Inspire Medical Systems Announces $86M IPO

The sleep apnea device maker is the sixth company out of Minnesota this year to register for an initial public offering.

U of M Institute with a ‘Bench-to-Bedside’ Mission Receives $42.6M Grant
U of M Institute with a ‘Bench-to-Bedside’ Mission Receives $42.6M Grant

The university’s Clinical and Translational Science Institute, which helps support research in various behind-the-scenes ways, awarded funds from the National Institutes of Health.

RxFunction, Medical Startup Behind Walkasins, Raises $7.5 Million
RxFunction, Medical Startup Behind Walkasins, Raises $7.5 Million

The funds will aid in commercialization of wearable technology geared toward improving balance and preventing falls.

Boston Scientific Signs $50M Deal for Securus Medical Group
Boston Scientific Signs $50M Deal for Securus Medical Group

Securus makes an advanced thermal monitoring system that can display the temperature of the esophagus during cardiac ablation procedures.

Vyaire Medical Closing Plymouth Plant, Eliminating 50 Jobs
Vyaire Medical Closing Plymouth Plant, Eliminating 50 Jobs

The respiratory device company informed Minnesota state officials of the decision, as legally required by the WARN Act.

Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials
Mayo Clinic Biotech Spin-Off Vyriad Raising $9M for Expansion, Clinical Trials

The Rochester firm will hire up to 30 new workers as it completes a new headquarters build-out.